Ran GTPase protein promotes human pancreatic cancer proliferation by deregulating the expression of Survivin and cell cycle proteins

Biochemical and Biophysical Research Communications

Volumn 440, Issue 2, 2013, Pages 322-329

  Deng, Lin ^a,b   Lu, Yuanyuan ^a   Zhao, Xiaodi ^a   Sun, Yi ^a   Shi, Yongquan ^a   Fan, Hongwei ^a   Liu, Changhao ^a   Zhou, Jinfeng ^a   Nie, Yongzhan ^a   Wu, Kaichun ^a   Fan, Daiming ^a   Guo, Xuegang ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cell cycle; Pancreatic cancer; Proliferation; Ran; Survivin

Indexed keywords

CASPASE 3; CELL CYCLE PROTEIN; CYCLIN A; CYCLIN D1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN E; GUANOSINE TRIPHOSPHATASE; RAN PROTEIN; RETINOBLASTOMA PROTEIN; SURVIVIN;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER GRADING; CANCER TISSUE; CARCINOGENESIS; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; G1 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION REGULATION; GENE INDUCTION; GENE OVEREXPRESSION; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MOUSE; NONHUMAN; NUCLEOCYTOPLASMIC TRANSPORT; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN CLEAVAGE; REAL TIME POLYMERASE CHAIN REACTION; TUMOR GROWTH; UPREGULATION; WESTERN BLOTTING;

CELL CYCLE; PANCREATIC CANCER; PROLIFERATION; RAN; SURVIVIN;

ANIMALS; CASPASE 3; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; FEMALE; G1 PHASE; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; MALE; MICE; MIDDLE AGED; PANCREATIC NEOPLASMS; RAN GTP-BINDING PROTEIN; S PHASE;

EID: 84885848755     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.09.079     Document Type: Article

References (37)

1. Raimondi S., Maisonneuve P., Lowenfels A.B. Epidemiology of pancreatic cancer: an overview. Nat. Rev. Gastroenterol. Hepatol. 2009, 6:699-708.
2. Vincent A., Herman J., Schulick R., Hruban R.H., Goggins M. Pancreatic cancer. Lancet 2011, 378:607-620.
3. Maitra A., Hruban R.H. Pancreatic cancer. Annu. Rev. Pathol. 2008, 3:157-188.
4. Wong H.H., Lemoine N.R. Pancreatic cancer: molecular pathogenesis and new therapeutic targets. Nat. Rev. Gastroenterol. Hepatol. 2009, 6:412-422.
5. Dasso M. Running on Ran: nuclear transport and the mitotic spindle. Cell 2001, 104:321-324.
6. Guttler T., Gorlich D. Ran-dependent nuclear export mediators: a structural perspective. EMBO J. 2011, 30:3457-3474.
7. Kau T.R., Way J.C., Silver P.A. Nuclear transport and cancer: from mechanism to intervention. Nat. Rev. Cancer 2004, 4:106-117.
8. Melo S.A., Moutinho C., Ropero S., Calin G.A., Rossi S., et al. A genetic defect in exportin-5 traps precursor microRNAs in the nucleus of cancer cells. Cancer Cell 2010, 18:303-315.
9. Clarke P.R., Klebe C., Wittinghofer A., Karsenti E. Regulation of Cdc2/Cyclin B activation by Ran, a Ras-related GTPase. J. Cell Sci. 1995, 108(Pt 3):1217-1225.
10. Dasso M. The Ran GTPase: theme and variations. Curr. Biol. 2002, 12:R502-R508.
11. Sazer S., Dasso M. The ran decathlon: multiple roles of Ran. J. Cell Sci. 2000, 113(Pt 7):1111-1118.
12. Clarke P.R., Zhang C. Spatial and temporal coordination of mitosis by Ran GTPase. Nat. Rev. Mol. Cell Biol. 2008, 9:464-477.
13. Abe H., Kamai T., Shirataki H., Oyama T., Arai K., et al. High expression of Ran GTPase is associated with local invasion and metastasis of human clear cell renal cell carcinoma. Int. J. Cancer 2008, 122:2391-2397.
14. Barres V., Ouellet V., Lafontaine J., Tonin P.N., Provencher D.M., et al. An essential role for Ran GTPase in epithelial ovarian cancer cell survival. Mol. Cancer 2010, 9:272.
15. Xia F., Lee C.W., Altieri D.C. Tumor cell dependence on Ran-GTP-directed mitosis. Cancer Res. 2008, 68:1826-1833.
16. Altieri D.C. The case for survivin as a regulator of microtubule dynamics and cell-death decisions. Curr. Opin. Cell Biol. 2006, 18:609-615.
17. Knauer S.K., Kramer O.H., Knosel T., Engels K., Rodel F., et al. Nuclear export is essential for the tumor-promoting activity of survivin. FASEB J. 2007, 21:207-216.
18. Brunner T.B., Cengel K.A., Hahn S.M., Wu J., Fraker D.L., et al. Pancreatic cancer cell radiation survival and prenyltransferase inhibition: the role of K-Ras. Cancer Res. 2005, 65:8433-8441.
19. Sazer S., Nurse P. A fission yeast RCC1-related protein is required for the mitosis to interphase transition. EMBO J. 1994, 13:606-615.
20. Kornbluth S., Dasso M., Newport J. Evidence for a dual role for TC4 protein in regulating nuclear structure and cell cycle progression. J. Cell Biol. 1994, 125:705-719.
21. Carazo-Salas R.E., Guarguaglini G., Gruss O.J., Segref A., Karsenti E., et al. Generation of GTP-bound Ran by RCC1 is required for chromatin-induced mitotic spindle formation. Nature 1999, 400:178-181.
22. Kalab P., Pu R.T., Dasso M. The ran GTPase regulates mitotic spindle assembly. Curr. Biol. 1999, 9:481-484.
23. Malumbres M., Barbacid M. To cycle or not to cycle: a critical decision in cancer. Nat. Rev. Cancer 2001, 1:222-231.
24. Murray A.W. Recycling the cell cycle: cyclins revisited. Cell 2004, 116:221-234.
25. Malumbres M., Barbacid M. Cell cycle, CDKs and cancer: a changing paradigm. Nat. Rev. Cancer 2009, 9:153-166.
26. Olashaw N., Pledger W.J. Paradigms of growth control: relation to Cdk activation. Sci. STKE 2002, 2002:re7.
27. Lundberg A.S., Weinberg R.A. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol. Cell Biol. 1998, 18:753-761.
28. Massague J. G1 cell-cycle control and cancer. Nature 2004, 432:298-306.
29. Ohtsubo M., Theodoras A.M., Schumacher J., Roberts J.M., Pagano M. Human Cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol. Cell. Biol. 1995, 15:2612-2624.
30. Yu Q., Sicinski P. Mammalian cell cycles without Cyclin E-CDK2. Cell Cycle 2004, 3:292-295.
31. Pagano M., Pepperkok R., Verde F., Ansorge W., Draetta G. Cyclin A is required at two points in the human cell cycle. EMBO J. 1992, 11:961-971.
32. Ambrosini G., Adida C., Altieri D.C. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat. Med. 1997, 3:917-921.
33. Li F., Ambrosini G., Chu E.Y., Plescia J., Tognin S., et al. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 1998, 396:580-584.
34. Shin S., Sung B.J., Cho Y.S., Kim H.J., Ha N.C., et al. An anti-apoptotic protein human survivin is a direct inhibitor of Caspase-3 and -7. Biochemistry 2001, 40:1117-1123.
35. Ai Z., Yin L., Zhou X., Zhu Y., Zhu D., et al. Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer. Cancer 2006, 107:746-756.
36. Stewart M. Cell biology. Nuclear export of small RNAs. Science 2009, 326:1195-1196.
37. Wong C.H., Chan H., Ho C.Y., Lai S.K., Chan K.S., et al. Apoptotic histone modification inhibits nuclear transport by regulating RCC1. Nat. Cell Biol. 2009, 11:36-45.